Skip to main content

Creative Medical Technology Holdings, Inc.

CELZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001187953

No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CELZ: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders12120
Shares69.9K70.7K+776 (+1.1%)
Value$185.4K$233.4K+$48.0K (+25.9%)

New holders (4)

Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CELZ in Q3 2025
InstitutionSharesValue% of portfolio
DRW Securities, LLC15,101$50.3K0.00%
Jones Financial Companies LLLP1,000$3.32K0.00%
FMR LLC200$6580.00%
SBI Securities Co., Ltd.1$30.00%

Sold out (4)

Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CELZ in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Northern Trust Corp11,707$31.0K
Citadel Advisors LLC11,145$29.5K
Ameritas Advisory Services, LLC2,276$6.03K
Tower Research Capital LLC (TRC)1,029$2.73K